A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease
Clinical trial NCT04537377 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04537377
- Sponsor
- Vivet Therapeutics SAS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2024-12-17
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.